February 16, 2023 01:17 PM ESTUpdated February 22, 04:55 PM
Manufacturing

Man­u­fac­tur­ing roundup: Life sci­ences de­vel­op­ment planned for Texas; Eli Lil­ly to sup­ply in­sulin in­gre­di­ent to Bangladesh

Tyler Patchen

News Reporter

New life sci­ence and pro­duc­tion fa­cil­i­ties may be com­ing to a Dal­las, TX sub­urb.

In­vest­ment com­pa­ny Nex­Point has an­nounced plans for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times